Andlauer Healthcare Group Inc. (TSE:AND) Receives Average Rating of “Moderate Buy” from Analysts

Shares of Andlauer Healthcare Group Inc. (TSE:ANDGet Free Report) have received an average rating of “Moderate Buy” from the seven brokerages that are currently covering the firm, Marketbeat.com reports. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average twelve-month price objective among brokers that have updated their coverage on the stock in the last year is C$48.57.

Several analysts recently commented on the stock. Scotiabank increased their target price on shares of Andlauer Healthcare Group from C$43.00 to C$44.00 in a research note on Thursday, November 7th. TD Securities increased their price objective on Andlauer Healthcare Group from C$53.00 to C$54.00 and gave the company a “buy” rating in a research report on Thursday, November 7th.

Check Out Our Latest Research Report on Andlauer Healthcare Group

Andlauer Healthcare Group Price Performance

Shares of Andlauer Healthcare Group stock opened at C$42.84 on Friday. Andlauer Healthcare Group has a 52 week low of C$36.43 and a 52 week high of C$44.92. The company has a current ratio of 1.35, a quick ratio of 1.66 and a debt-to-equity ratio of 41.86. The company’s 50-day moving average price is C$42.22 and its two-hundred day moving average price is C$40.27. The stock has a market cap of C$801.11 million, a PE ratio of 28.18 and a beta of 0.66.

Andlauer Healthcare Group Company Profile

(Get Free Report

Andlauer Healthcare Group Inc, a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics.

Recommended Stories

Analyst Recommendations for Andlauer Healthcare Group (TSE:AND)

Receive News & Ratings for Andlauer Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Andlauer Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.